MINICOCCI, ILENIA
 Distribuzione geografica
Continente #
NA - Nord America 1.258
EU - Europa 648
AS - Asia 257
AF - Africa 13
SA - Sud America 9
OC - Oceania 6
Totale 2.191
Nazione #
US - Stati Uniti d'America 1.244
IT - Italia 359
SG - Singapore 143
SE - Svezia 85
IN - India 51
DE - Germania 49
CN - Cina 47
FI - Finlandia 39
FR - Francia 20
GB - Regno Unito 20
BG - Bulgaria 19
UA - Ucraina 15
CA - Canada 11
RU - Federazione Russa 11
TG - Togo 11
AR - Argentina 8
NL - Olanda 8
ID - Indonesia 7
IR - Iran 7
AU - Australia 5
BE - Belgio 5
RO - Romania 5
GR - Grecia 4
MX - Messico 3
ES - Italia 2
IE - Irlanda 2
NO - Norvegia 2
TZ - Tanzania 2
CH - Svizzera 1
CL - Cile 1
KH - Cambogia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 2.191
Città #
Fairfield 161
Rome 149
Singapore 117
Chandler 115
Ashburn 101
Woodbridge 72
Houston 64
Santa Clara 60
Cambridge 59
Wilmington 58
Seattle 49
Beijing 33
New York 30
Princeton 27
Ann Arbor 26
San Diego 24
Helsinki 23
Sofia 19
Lawrence 18
Plano 18
Boston 16
Milan 15
Millbury 13
San Paolo di Civitate 13
Fremont 11
Lomé 11
Dearborn 10
Moscow 10
Cagliari 9
Los Angeles 8
Rochester 8
Andover 7
Des Moines 7
Falls Church 7
Jakarta 7
Bari 6
Melville 6
Ottawa 6
Bologna 5
Chapel Hill 5
Federal 5
Toronto 5
Florence 4
London 4
Marseille 4
Noci 4
Turin 4
Brescia 3
Bromley 3
Brussels 3
Budrio 3
Edmonton 3
Falkenstein 3
Jacksonville 3
Kunming 3
Mexico City 3
Norwalk 3
Palermo 3
Redwood City 3
Seregno 3
Stockholm 3
Tehran 3
Treviso 3
Berlin 2
Boardman 2
Buenos Aires 2
Bühl 2
Capaccio 2
Catania 2
Cercola 2
Chioggia 2
Cisliano 2
Dar es Salaam 2
Dublin 2
Frankfurt am Main 2
Gelsenkirchen 2
Giessenburg 2
Hamar 2
Lappeenranta 2
Lucera 2
Lyon 2
Mannheim 2
Melbourne 2
Naples 2
Nikaia 2
Paris 2
Pescorocchiano 2
Pinto 2
Pune 2
Rivoli 2
Sacramento 2
Salerno 2
San Giovanni Rotondo 2
San Vito sullo Ionio 2
Santa Clarita 2
St Louis 2
Sydney 2
Trescore Balneario 2
Vazzola 2
Waanrode 2
Totale 1.555
Nome #
Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism 145
Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes 101
Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis 97
Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia 96
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): A reappraisal by using a resequencing approach 88
CLINICAL CHARACTERISTICS AND PLASMA LIPIDS IN SUBJECTS WITH FAMILIAL COMBINED HYPOLIPIDEMIA: A POOLED ANALYSIS 85
Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State 85
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis 84
Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids 84
Twelve variants polygenic score for low-density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with or without causative mutations 80
Analysis of Children and Adolescents with Familial Hypercholesterolemia 80
Metabolic Consequences of Adipose Triglyceride Lipase Deficiency in Humans: An In Vivo Study in Patients With Neutral Lipid Storage Disease With Myopathy 78
Evaluation of the performance of dutch lipid clinic network score in an Italian fh population: the lipigen study 78
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: An exploratory analysis 78
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: a retrospective, single center, observational study 69
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells 67
How ANGPTL3 Inhibition Will Help Our Clinical Practice? 66
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: a comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia 66
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes 59
The interplay between angiopoietin-like proteins and adipose tissue: Another piece of the relationship between adiposopathy and cardiometabolic diseases? 57
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content 55
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway 55
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: implications for clinical diagnosis 51
Mutations in the ANGPTL3 gene and familial combined hypolipidemia: A clinical and biochemical characterization 50
The angiopoietin-like protein 3: A hepatokine with expanding role in metabolism 48
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins 37
Familial combined hypolipidemia: Angiopoietin-like protein-3 deficiency 37
Individuazione della causa genetica responsabile della ipocolesterolemia nelle famiglie di Campodimele (LT) 35
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study 34
S17 X LOSS OF FUNCTION (LOF) MUTATION IN ANGIOPOIETIN LIKE 3 (ANGPTL3) IS ASSOCIATED WITH INCREASED PLASMA LIPOPROTEIN LIPASE ACTIVITY AND CHANGES IN LIPOPROTEIN COMPOSITION 33
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 32
null 29
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis 25
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells 24
Clinical implications of monogenic versus polygenic hypercholesterolemia: long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events 24
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 23
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4 19
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 16
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 14
Effects of lenvatinib on glucose, cholesterol, triglycerides and estimated cardiovascular risk in patients with advanced thyroid cancer 13
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia. evidence from the LIPIGEN study 11
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease 10
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment 10
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 7
null 5
null 3
Clinical implications of monogenic versus polygenic hypercholesterolemia: Long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events 3
Totale 2.346
Categoria #
all - tutte 8.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020224 0 0 0 0 0 28 59 37 36 33 21 10
2020/2021212 12 15 8 10 4 15 3 33 26 68 18 0
2021/2022406 7 19 26 10 48 21 11 29 34 24 123 54
2022/2023464 66 82 30 47 37 41 20 58 40 6 27 10
2023/2024394 31 39 19 25 35 90 14 17 14 27 45 38
2024/2025339 21 91 50 47 75 55 0 0 0 0 0 0
Totale 2.346